early-lineage stem cells used in research-stage protocols.
Fetal stem cells carry broad differentiation potential and low immunogenicity. They form the historical core of several European regenerative programmes and remain a defined research area.
The therapeutic value of Fetal Stem Cells lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.
Educational information. Fetal Stem Cells protocols for several conditions remain investigational; outcomes vary by patient.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起,仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估